Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Pharmacogenomic Guided Versus Standard Pharmacist Care to Optimize Antidepressant Drug Therapy in a Community Pharmacy Setting

NCT03591224 is registered in ClinicalTrials.gov with John Papastergiou Pharmacy Ltd as lead sponsor.

NCT NCT03591224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03591224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Pharmacogenomic Guided Versus Standard Pharmacist Care to Optimize Antidepressant Drug Therapy in a Community Pharmacy Setting
Lead sponsor
John Papastergiou Pharmacy Ltd
Phase
Not applicable
Overall status
Completed
Start date
April 17, 2018
Completion date
December 31, 2019
Enrollment
213 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depression, generalized anxiety disorder, major depressive disorder, mood disorders